Splicing diversity of the human OCLN gene and its biological significance for hepatitis C virus entry.
Persistent hepatitis C virus (HCV) infection is a primary etiological factor for the development of chronic liver disease, including cirrhosis and cancer. A recent study identified occludin (OCLN), an integral tight junction protein, as one of the key factors for HCV entry into cells. We explored the splicing diversity of OCLN in normal human liver and observed variable expression of alternative splice variants, including two known forms (WT-OCLN and OCLN-ex4del) and six novel forms (OCLN-ex7ext, OCLN-ex3pdel, OCLN-ex3del, OCLN-ex3-4del, OCLN-ex3p-9pdel, and OCLN-ex3p-7pdel). Recombinant protein isoforms WT-OCLN and OCLN-ex7ext, which retained the HCV-interacting MARVEL domain, were expressed on the cell membrane and were permissive for HCV infection in in vitro infectivity assays. All other forms lacked the MARVEL domain, were expressed in the cytoplasm, and were nonpermissive for HCV infection. Additionally, we observed variable expression of OCLN splicing forms across human tissues and cell lines. Our study suggests that the remarkable natural splicing diversity of OCLN might contribute to HCV tissue tropism and possibly modify the outcome of HCV infection in humans. Genetic factors crucial for regulation of OCLN expression and susceptibility to HCV infection remain to be elucidated.
Kohaar
Indu
I
Laboratory of Translational Genomics, National Cancer Institute, National Institutes of Health, 8717 Grovemont Circle, Bethesda, MD 20892-4605, USA.
Ploss
Alexander
A
Korol
Evgenia
E
Mu
Kathy
K
Schoggins
John W
JW
O'Brien
Thomas R
TR
Rice
Charles M
CM
Prokunina-Olsson
Ludmila
L
D017398:Alternative Splicing; D002884:Chromosomes, Human, Pair 15; D005091:Exons; D006367:HeLa Cells; D016174:Hepacivirus / Q000235:genetics / Q000502:physiology*; D019698:Hepatitis C, Chronic / Q000150:complications / Q000503:physiopathology; D006801:Humans; D008099:Liver / Q000502:physiology / Q000821:virology; D008113:Liver Neoplasms / Q000209:etiology / Q000821:virology; D008565:Membrane Proteins / Q000235:genetics* / Q000378:metabolism; D008969:Molecular Sequence Data; D062793:Occludin; D020033:Protein Isoforms / Q000235:genetics / Q000378:metabolism; D014018:Tissue Distribution; D053586:Virus Internalization
D008565:Membrane Proteins; C568985:OCLN protein, human; D062793:Occludin; D020033:Protein Isoforms
Trends Biochem Sci. 2002 Dec;27(12):599-601
12468223
Biochem Biophys Res Commun. 1995 Jan 26;206(3):863-9
7832798
Nat Genet. 2009 Oct;41(10):1048-50
19749756
Nature. 2009 Feb 12;457(7231):882-6
19182773
J Cell Sci. 2002 Aug 1;115(Pt 15):3171-80
12118072
Int J Cancer. 1999 Mar 15;80(6):827-41
10074914
Hepatology. 2008 Dec;48(6):1843-50
19003912
Ann N Y Acad Sci. 2002 Jun;963:13-20
12095924
CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
15761078
J Cell Biol. 1993 Dec;123(6 Pt 2):1777-88
8276896
Mol Biol Cell. 2000 Feb;11(2):627-34
10679019
Biochem Biophys Res Commun. 2002 Nov 15;298(5):657-66
12419305
J Cell Biol. 1996 Apr;133(1):43-7
8601611
Cell. 2000 Apr 14;101(2):173-85
10786833
FEBS J. 2008 Jun;275(12):3145-56
18489585
Science. 1996 Mar 29;271(5257):1873-6
8596958
Mol Ther. 2001 Apr;3(4):438-48
11319904
Semin Liver Dis. 2005;25(2):143-54
15918143
Am J Med. 2007 Mar;120(3):194-202
17349437
Expert Rev Vaccines. 2009 Mar;8(3):333-45
19249975
J Mol Biol. 2005 Sep 9;352(1):151-64
16081103
J Med Virol. 2007 Jan;79(1):92-6
17133558
J Cell Sci. 2000 Jun;113 ( Pt 11):2085-90
10806119
J Virol. 2009 Feb;83(4):2011-4
19052094